➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Express Scripts
Harvard Business School
Johnson and Johnson
Baxter

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Inotuzumab ozogamicin - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for inotuzumab ozogamicin
Tradenames:1
Patents:17
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for inotuzumab ozogamicin
Recent Clinical Trials for inotuzumab ozogamicin

Identify potential brand extensions & biosimilar entrants

SponsorPhase
NordForskPhase 3
Acreditar - Associação de Pais e Amigos das Crianças com CancroPhase 3
The Swedish Research CouncilPhase 3

See all inotuzumab ozogamicin clinical trials

Patent Text Search: US Patents for inotuzumab ozogamicin

These patents were identified by searching patent claims

Supplementary Protection Certificates for inotuzumab ozogamicin

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2017 00053 Denmark   Start Trial PRODUCT NAME: ANTISTOF-LAEGEMIDDEL-KONJUGAT, HVORI ET CD22-RETTET ANTISTOF ER BUNDET TIL N-ACETYL-GAMMA-CALICHEAMICIN, SVARENDE TIL INOTUZUMAB OZOGAMICIN; REG. NO/DATE: EU/1/17/1200 20170703
2017 00053 Denmark   Start Trial PRODUCT NAME: ANTISTOF-LAEGEMIDDEL-KONJUGAT, HVORI ET CD22-RETTET ANTISTOF ER KOVALENT BUNDET TIL N-ACETYL-GAMMA-CALICHEAMICIN DIMETHYLHYDRAZID, SVARENDE TIL INOTUZUMAB OZOGAMICIN; REG. NO/DATE: EU/1/17/1200 20170703
01730059 Spain   Start Trial PRODUCT NAME: INOTUZUMAB OZOGAMICINA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1200; DATE OF AUTHORISATION: 20170629; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1200; DATE OF FIRST AUTHORISATION IN EEA: 20170629
2017036,C2371392 Lithuania   Start Trial PRODUCT NAME: INOTUZUMABO OZOGAMICINAS; REGISTRATION NO/DATE: EU/1/17/1200 20170629
17C/049 Belgium   Start Trial PRODUCT NAME: INOTUZUMAB OZOGAMICIN; AUTHORISATION NUMBER AND DATE: EU/1/17/1200 20170703
90057-2 Sweden   Start Trial PRODUCT NAME: INOTUZUMAB OZOGAMICIN; REG. NO/DATE: EU/1/17/1200 20170703
0903 Netherlands   Start Trial PRODUCT NAME: INOTUZUMAB OZOGAMICIN; REGISTRATION NO/DATE: EU/1/17/1200 20170703
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Johnson and Johnson
McKinsey
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.